Traws Pharma, Inc. Operating Cash Flow
Traws Pharma, Inc. (TRAW) reported Operating Cash Flow of -$10.08 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- Traws Pharma, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$7.50M.
- Traws Pharma, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$2.58M.
- Traws Pharma, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$2.76M.
- Traws Pharma, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$4.01M.
- Traws Pharma, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$18.18M.
- Traws Pharma, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$29.79M.
- Traws Pharma, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$17.93M.
- Traws Pharma, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$16.29M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$7.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$10.08M 10-Q · filed 2026-08-14 | -$12.84M derived: sum of 3 quarters · filed 2026-08-14 | -$16.85M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$2.58M 10-Q · filed 2026-05-15 | -$5.33M derived: sum of 2 quarters · filed 2026-05-15 | -$9.35M derived: sum of 3 quarters · filed 2026-05-15 | -$15.32M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$2.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$6.77M derived: sum of 2 quarters · filed 2026-04-15 | -$12.75M derived: sum of 3 quarters · filed 2026-08-14 | -$18.18M 10-K · filed 2026-04-15 |
| 2025-09-30 | -$4.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$9.99M derived: sum of 2 quarters · filed 2026-08-14 | -$15.43M 10-Q · filed 2025-11-13 | -$19.47M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$5.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$11.42M 10-Q · filed 2026-08-14 | -$15.46M derived: sum of 3 quarters · filed 2026-08-14 | -$26.93M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$5.44M 10-Q · filed 2026-05-15 | -$9.48M derived: sum of 2 quarters · filed 2026-05-15 | -$20.95M derived: sum of 3 quarters · filed 2026-05-15 | -$30.80M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$4.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$15.52M derived: sum of 2 quarters · filed 2026-04-15 | -$25.37M derived: sum of 3 quarters · filed 2026-04-15 | -$29.79M 10-K · filed 2026-04-15 |
| 2024-09-30 | -$11.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$21.33M derived: sum of 2 quarters · filed 2025-11-13 | -$25.75M 10-Q · filed 2025-11-13 | -$30.18M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$9.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$14.28M 10-Q · filed 2025-08-14 | -$18.71M derived: sum of 3 quarters · filed 2025-08-14 | -$23.18M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$4.42M 10-Q · filed 2025-05-15 | -$8.85M derived: sum of 2 quarters · filed 2025-05-15 | -$13.32M derived: sum of 3 quarters · filed 2025-05-15 | -$17.81M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$4.43M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$8.90M derived: sum of 2 quarters · filed 2025-03-31 | -$13.39M derived: sum of 3 quarters · filed 2025-03-31 | -$17.93M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$4.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$8.96M derived: sum of 2 quarters · filed 2024-11-14 | -$13.50M 10-Q · filed 2024-11-14 | -$17.39M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$4.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-15 | -$9.03M 10-Q · filed 2024-08-15 | -$12.92M derived: sum of 3 quarters · filed 2024-08-15 | -$16.82M derived: sum of 4 quarters · filed 2024-08-15 |
| 2023-03-31 | -$4.54M 10-Q · filed 2024-05-15 | -$8.43M derived: sum of 2 quarters · filed 2024-05-15 | -$12.33M derived: sum of 3 quarters · filed 2024-05-15 | -$16.54M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$3.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$7.78M derived: sum of 2 quarters · filed 2024-04-01 | -$12.00M derived: sum of 3 quarters · filed 2024-04-01 | -$16.29M 10-K · filed 2024-04-01 |
| 2022-09-30 | -$3.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$8.11M derived: sum of 2 quarters · filed 2023-11-14 | -$12.41M 10-Q · filed 2023-11-14 | -$16.68M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$4.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$8.51M 10-Q · filed 2023-08-14 | -$12.78M derived: sum of 3 quarters · filed 2023-08-14 | -$17.04M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$4.30M 10-Q · filed 2023-05-15 | -$8.56M derived: sum of 2 quarters · filed 2023-05-15 | -$12.83M derived: sum of 3 quarters · filed 2023-05-15 | -$17.14M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$4.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$8.53M derived: sum of 2 quarters · filed 2023-03-30 | -$12.84M derived: sum of 3 quarters · filed 2023-03-30 | -$19.49M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$4.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$8.57M derived: sum of 2 quarters · filed 2022-11-14 | -$15.22M 10-Q · filed 2022-11-14 | -$20.69M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$4.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$10.96M 10-Q · filed 2022-08-15 | -$16.42M derived: sum of 3 quarters · filed 2022-08-15 | -$22.19M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$6.65M 10-Q · filed 2022-05-13 | -$12.12M derived: sum of 2 quarters · filed 2022-05-13 | -$17.88M derived: sum of 3 quarters · filed 2022-05-13 | -$23.26M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | -$5.47M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | -$11.23M derived: sum of 2 quarters · filed 2022-03-21 | -$16.61M derived: sum of 3 quarters · filed 2022-03-21 | -$23.07M 10-K · filed 2022-03-21 |
| 2020-09-30 | -$5.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$11.14M derived: sum of 2 quarters · filed 2021-11-15 | -$17.61M 10-Q · filed 2021-11-15 | -$22.97M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | -$5.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$11.84M 10-Q · filed 2021-08-16 | -$17.20M derived: sum of 3 quarters · filed 2021-08-16 | -$21.16M derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | -$6.46M 10-Q · filed 2021-05-17 | -$11.82M derived: sum of 2 quarters · filed 2021-05-17 | -$15.78M derived: sum of 3 quarters · filed 2021-05-17 | -$20.69M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | -$5.36M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$9.32M derived: sum of 2 quarters · filed 2021-03-18 | -$14.23M derived: sum of 3 quarters · filed 2021-03-18 | -$20.83M 10-K · filed 2021-03-18 |
| 2019-09-30 | -$3.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$8.87M derived: sum of 2 quarters · filed 2020-11-16 | -$15.47M 10-Q · filed 2020-11-16 | -$20.88M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | -$4.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$11.51M 10-Q · filed 2020-08-12 | -$16.92M derived: sum of 3 quarters · filed 2020-08-12 | -$24.07M derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | -$6.60M 10-Q · filed 2020-05-15 | -$12.01M derived: sum of 2 quarters · filed 2020-05-15 | -$19.16M derived: sum of 3 quarters · filed 2020-05-15 | -$23.79M derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | -$5.41M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$12.56M derived: sum of 2 quarters · filed 2020-03-27 | -$17.19M derived: sum of 3 quarters · filed 2020-03-27 | -$22.70M 10-K · filed 2020-03-27 |
| 2018-09-30 | -$7.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$11.78M derived: sum of 2 quarters · filed 2019-11-12 | -$17.29M 10-Q · filed 2019-11-12 | -$21.96M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | -$4.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$10.13M 10-Q · filed 2019-08-14 | -$14.81M derived: sum of 3 quarters · filed 2019-08-14 | -$22.20M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | -$5.51M 10-Q · filed 2019-05-15 | -$10.18M derived: sum of 2 quarters · filed 2019-05-15 | -$17.58M derived: sum of 3 quarters · filed 2019-05-15 | -$23.27M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | -$4.67M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$12.07M derived: sum of 2 quarters · filed 2019-04-01 | -$17.76M derived: sum of 3 quarters · filed 2019-04-01 | -$23.82M 10-K · filed 2019-04-01 |
| 2017-09-30 | -$7.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$13.09M derived: sum of 2 quarters · filed 2018-11-14 | -$19.15M 10-Q · filed 2018-11-14 | -$23.51M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | -$5.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$11.75M 10-Q · filed 2018-08-14 | -$16.11M derived: sum of 3 quarters · filed 2018-08-14 | -$18.97M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | -$6.06M 10-Q · filed 2018-05-15 | -$10.42M derived: sum of 2 quarters · filed 2018-05-15 | -$13.28M derived: sum of 3 quarters · filed 2018-05-15 | |
| 2016-12-31 | -$4.36M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$7.22M derived: sum of 2 quarters · filed 2018-03-16 | -$15.81M 10-K · filed 2018-03-16 | |
| 2016-09-30 | -$2.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$11.45M 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | -$8.59M 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |